Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
trastuzumab deruxtecan
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
trastuzumab deruxtecan
Unique ID
C000614160
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000614160
Entry Term(s)
DS-8201
DS-8201a
Registry Numbers
5384HK7574
Heading Mapped to
Camptothecin
/
analogs & derivatives
*Immunoconjugates
*Trastuzumab
Frequency
108
Note
has both
DNA
topoisomerase I inhibitory and antineoplastic activities; consists of
DX-8951
conjugated to a humanized antiāHER2 antibody; structure in first source
Source
Cancer Sci. 2016 Jul;107(7):1039-46.
Date of Entry
2017/02/12
Revision Date
2020/08/24
Expand All
Collapse All
trastuzumab deruxtecan
Preferred
Concept UI
M000654401
Registry Numbers
5384HK7574
Terms
trastuzumab deruxtecan
Preferred Term
Term UI
T000965894
Date
08/20/2019
LexicalTag
NON
ThesaurusID
DS-8201a
Narrower
Concept UI
M000626452
Terms
DS-8201a
Preferred Term
Term UI
T000915692
Date
02/12/2017
LexicalTag
LAB
ThesaurusID
NLM (2017)
DS-8201
Term UI
T000965895
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
page delivered in 0.004s